Janus Henderson Group
BMY.RT

Janus Henderson Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Janus Henderson Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-29,785,990
Closed -$20.6M – 1660
2020
Q4 		$20.6M Buy
29,785,990
+5,673,913
+24% +$12.1M 0.01% 745
2020
Q3 		$54.3M Buy
24,112,077
+7,111,034
+42% +$20.3M 0.03% 478
2020
Q2 		$60.9M Buy
17,001,043
+3,496,513
+26% +$12.6M 0.03% 441
2020
Q1 		$51.3M Sell
13,504,530
-863,948
-6% -$2.85M 0.04% 453
2019
Q4 		$43.3M Buy
+14,368,478
New +$37.4M 0.02% 635

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Janus Henderson Group's BMY.RT Position: Q1 2021 in Review

Janus Henderson Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 29,785,990 shares — an estimated $20.6M sold.

Janus Henderson Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $60.9M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Janus Henderson Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Janus Henderson Group sold 29,785,990 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $20.6M.
  • Janus Henderson Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Janus Henderson Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $60.9M in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Janus Henderson Group's 13F filing for Q1 2021, filed 17 May 2021.